July 16, 2021 - IU Research Impact

Alzheimer’s, dementia research expanded at IU School of Medicine through $30M NIH grant

Tatiana Foroud

With new funding through the National Institutes of Health, the National Centralized Repository for Alzheimer’s Disease and Related Dementias, based at the IU School of Medicine and led by Tatiana Foroud (above), will engage diverse communities to collect biological samples that will help advance a wide range of Alzheimer’s and dementia research.

Read more about the NCRAD and its work

New nanoparticles with high-tech applications found

IUPUI researchers have discovered new high-entropy nanoparticles that have potential high-tech applications in areas such as energy storage and space travel.

Read more about the discovery

Helping youth affected by substance abuse

IUPUI students and future health care workers learn about substance use disorder while serving as mentors at Camp Mariposa-Aaron’s Place, a camp for youth impacted by addiction.

Read more about the camp's work

What underlies inconsistent results in clinical trials for COVID-19 drugs?

An effective antiviral drug for COVID-19 would have significant global health benefits. But clinical drug trials have produced inconsistent results. IU findings suggest a new approach to recruiting participants could help.

Read more about the research

Prenatal exposure to THC, CBD affects response to common anxiety drug

A new study by IU scientists is one of the first to examine the effects of THC and CBD on the developing brain.


Read more about the study

Resources and events